Metraipolis › archive › dc_40e6d92dafde

Comparative effectiveness and safety of ondansetron-based dual versus triple antiemetic regimens for chemotherapy-induced nausea and vomiting — Europe PMC PMID:42432981

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42432981
DOI
10.1097/md.0000000000049639
License (as archived)
solo-consultazione
Archived
2026-10-18T14:15:30.882Z
SHA-256 of the archived text
84ee17c964044cacc8ba4e7c63310fdeccad532661ad45bc6413f2a2b6ee51fe
Stable URL of this page
https://metraipolis.com/documento/dc_40e6d92dafde

How to cite

Comparative effectiveness and safety of ondansetron-based dual versus triple antiemetic regimens for chemotherapy-induced nausea and vomiting — Europe PMC PMID:42432981 — Europe PMC (en), https://europepmc.org/article/MED/42432981 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_40e6d92dafde (Metraipolis archive dc_40e6d92dafde, sha256 84ee17c964044cacc8ba4e7c63310fdeccad532661ad45bc6413f2a2b6ee51fe)
BibTeX
@misc{dc40e6d92dafde,
  title = {Comparative effectiveness and safety of ondansetron-based dual versus triple antiemetic regimens for chemotherapy-induced nausea and vomiting — Europe PMC PMID:42432981},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42432981},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_40e6d92dafde; sha256 84ee17c964044cacc8ba4e7c63310fdeccad532661ad45bc6413f2a2b6ee51fe},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42432981. Agents can read the archived copy with the MCP tool read_document.